ICL Group Ltd ICL · NYSE
$4.94 -1.69% (-$0.09)
Summary
56 / 100 · Bulios Score
What speaks for it
- It has been profitable 6 years in a row.
- It could repay all its net debt from 1.9 years of operating profit.
What to watch
- Revenue fell by 11% a year over the last 3 years.
- It cut its dividend by 11% last year.
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensivePrice against the Bulios Fair Price
P/E against its own last 5 years
P/E against the industry (Agricultural Inputs)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 21.2 USD for 1 USD of yearly profit. Over the last five years it was 15.7 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 7.2% a year over 5 years. Over the last 3 years it fell by 11% a year. Earnings per share fell by 52% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 69 USD
- Research and development 0.8 USD
- Sales and administration 19 USD
- Taxes and other 6.8 USD
- Net profit 4.0 USD
Net profit, industry median (Agricultural Inputs) 8.0 USD
Out of every 100 USD of revenue, 4.0 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 11.3 years of free cash flow. Its debt is larger than its cash. The debt score is high even so.
Financial health in detailDoes it pay a dividend?
High, stretched- Yield
- 4.10%
- Paid out of profit
- 87%
You receive $0.21 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 4
- Sell 0
Today's price within the analysts' price targets
The average target of $6.08 is 23% above today's price. 0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.